Angelo Santoliquido

Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development

Maria Assunta Zocco, Enrico Di Stasio, Raimondo De Cristofaro et al. · Journal of Hepatology · 2009 · 465 citations

Hepatology, Thrombotic Risk Factors, Liver Physiology +11

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth

Gabriella Nucera, Maurizio Gabrielli, A. Lupascu et al. · Alimentary Pharmacology & Therapeutics · 2005 · 208 citations · Full text

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome

A. Lupascu, Maurizio Gabrielli, E.C. Lauritano et al. · Alimentary Pharmacology & Therapeutics · 2005 · 181 citations

Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth

E.C. Lauritano, Maurizio Gabrielli, A. Lupascu et al. · Alimentary Pharmacology & Therapeutics · 2005 · 120 citations · Full text

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis

Angelo Santoliquido, Angelo Porfidia, Antonio Nesci et al. · Journal of Thrombosis and Haemostasis · 2020 · 118 citations · Full text

Non‐icu Patients, Thrombosis, Venous Thrombosis +10